Table 2.
receptor type | density | species | references | |
---|---|---|---|---|
VIP | VPAC1 | 2/5 | rat | Joo et al., 2004 |
VPAC2 | 4/5 | |||
PAC1 | 0/5 | |||
neuropeptide Y | Y1 | 3/3 | rat | Parker and Herzog, 1999 |
Y2 | 1/3 | |||
Y4 | 0/3 | |||
Y5 | 2/3 | |||
histamine | H1 | 3/4 | human, rat | Jin et al., 2002 and 2005 |
H2 | 1/4 | |||
H3 | 3/4 | |||
neuropeptide S | NPS | 2/4 | rat | Xu et al., 2007 |
prokineticin | PK1 | 0/4 | mouse | Cheng et al., 2006 |
PK2 | 4/4 | |||
glucocorticoid | GR | 2/3 | rat | Morimoto et al., 1996 |
estrogen | beta | 2/3 | mouse | Mitra et al., 2003 |
CRH | CRF1 | 3/4 | mouse | Chen et al., 2000 |
melanocortin | MCHR | 2/4 | rat | Saito et al., 2001 |
adenosine | A1 | 4/4 | rat | Ochiishi et al., 1999 |
oxytocin | OxR | 2/4 | rat | Yoshimura et al., 1993 |
opioids | mu | 2/3 | rat | Ding et al., 1996 |
delta | 0/3 | George et al., 1994 | ||
kappa | 3/3 | |||
GABAb | GABAbR1 | 3/5 | rat | Margeta-Mitrovic et al., 1999 |
metabotropic | mGluR1 | 2/3 | rat | Neto et al., 2000 |
glutamate | mGluR5 | 1/3 | ||
mGluR4 | 2/3 | |||
mGluR7 | 1/3 | |||
cholecystokinin | CCKB | present | rat | Bhatnagar et al., 2000 |
substance P | NK1 | 4/4 | monkey | Rigby et al., 2005 |
NK2 | 0/4 | |||
NK3 | 1/4 | |||
dopamine | D2/3 | high | human | Rieck et al., 2004 |
leptin | LepRb | 1/4 | mouse | Scott et al., 2009 |
cannabinoid | CB1 | 1/4 | rat | Jelsing et al., 2008 |
CB2 | light | rat | Gong et al., 2006 | |
muscarinic | M1 | 2/3 | rat | Mash and Potter, 1986 |
M2 | 2/3 | rat | ||
M3 | moderate | rat | Levey et al., 1994 |
Most data refer to receptor mRNA analyses. Receptor densities are directly copied from actual references.